Insider Trading & Ownership - Reilly Thomas Charles

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Reilly Thomas Charles
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-03-03
Sale
2022-03-04
5:54 pm
Cara Therapeutics Inc.CARAReilly Thomas Charles
Chief Financial Officer
2,044$11.38$23,26137,811
(Direct)
View
2021-08-30
Sale
2021-09-01
6:08 pm
Cara Therapeutics Inc.CARAReilly Thomas Charles
Chief Financial Officer
1,982$14.2$28,1443,352
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-01
Option Award
2024-02-09
4:30 pm
N/A
N/A
AMARIN CORP PLCAMRNReilly Thomas Charles
EVP and CFO
534,000$0534,000
(Direct)
View
2024-01-31
Tax Withholding
2024-02-02
4:30 pm
N/A
N/A
AMARIN CORP PLCAMRNReilly Thomas Charles
EVP and CFO
24,552$1.24158,798
(Direct)
View
2024-01-31
Exercise
2024-02-02
4:30 pm
N/A
N/A
AMARIN CORP PLCAMRNReilly Thomas Charles
EVP and CFO
44,933$0158,798
(Direct)
View
2024-01-10
Option Award
2024-01-12
5:27 pm
N/A
N/A
AMARIN CORP PLCAMRNReilly Thomas Charles
EVP and CFO
51,500$048,550
(Direct)
View
2024-01-10
Tax Withholding
2024-01-12
5:27 pm
N/A
N/A
AMARIN CORP PLCAMRNReilly Thomas Charles
EVP and CFO
28,325$0.9748,550
(Direct)
View
2024-01-10
Exercise
2024-01-12
5:27 pm
N/A
N/A
AMARIN CORP PLCAMRNReilly Thomas Charles
EVP and CFO
51,500$048,550
(Direct)
View
2023-07-19
Option Award
2023-07-21
5:01 pm
N/A
2033-07-19
AMARIN CORP PLCAMRNReilly Thomas Charles
SVP and CFO
404,400$1.08404,400
(Direct)
View
2023-07-01
Tax Withholding
2023-07-05
4:46 pm
N/A
N/A
AMARIN CORP PLCAMRNReilly Thomas Charles
SVP and CFO
8,209$1.1958,708
(Direct)
View
2023-07-01
Exercise
2023-07-05
4:46 pm
N/A
N/A
AMARIN CORP PLCAMRNReilly Thomas Charles
SVP and CFO
16,667$058,708
(Direct)
View
2023-06-20
Tax Withholding
2023-06-22
5:10 pm
N/A
N/A
AMARIN CORP PLCAMRNReilly Thomas Charles
SVP and CFO
16,417$1.1983,583
(Direct)
View
2023-06-20
Exercise
2023-06-22
5:10 pm
N/A
N/A
AMARIN CORP PLCAMRNReilly Thomas Charles
SVP and CFO
33,334$083,583
(Direct)
View
2023-02-21
Option Award
2023-02-23
9:43 pm
N/A
2033-02-21
AMARIN CORP PLCAMRNReilly Thomas Charles
SVP and CFO
454,400$0454,400
(Direct)
View
2022-07-01
Option Award
2022-07-06
8:11 pm
N/A
2032-07-01
AMARIN CORP PLCAMRNReilly Thomas Charles
SVP and CFO
200,000$0200,000
(Direct)
View
2022-02-25
Option Award
2022-03-01
4:18 pm
N/A
2032-02-25
Cara Therapeutics Inc.CARAReilly Thomas Charles
Chief Financial Officer
60,000$079,855
(Direct)
View
2022-02-28
Option Award
2022-03-01
4:18 pm
N/A
N/A
Cara Therapeutics Inc.CARAReilly Thomas Charles
Chief Financial Officer
5,333$10.2979,855
(Direct)
View
2021-12-17
Option Award
2021-12-21
5:26 pm
N/A
N/A
Cara Therapeutics Inc.CARAReilly Thomas Charles
Chief Financial Officer
11,170$014,522
(Direct)
View
2021-08-24
Option Award
2021-08-26
6:18 pm
N/A
N/A
Cara Therapeutics Inc.CARAReilly Thomas Charles
Chief Financial Officer
5,334$05,334
(Direct)
View
2020-10-01
Option Award
2020-10-07
4:50 pm
N/A
2030-10-01
Cara Therapeutics Inc.CARAReilly Thomas Charles
Chief Financial Officer
175,000$0175,000
(Direct)
View